ENDLOS-TURBO PUT - ABBVIE Share Price

Certificat

DE000DJ2GX94

Market Closed - Deutsche Boerse AG 20:35:04 14/06/2024 BST
2.58 EUR -8.19% Intraday chart for ENDLOS-TURBO PUT - ABBVIE
Current month-25.65%
1 month-20.86%
Date Price Change
14/06/24 2.58 -8.19%
13/06/24 2.81 -2.09%
12/06/24 2.87 +7.09%
11/06/24 2.68 +10.29%
10/06/24 2.43 -2.02%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 08:35 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying ABBVIE INC.
Issuer DZ BANK
WKN DJ2GX9
ISINDE000DJ2GX94
Date issued 18/09/2023
Strike 196.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.308
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.83
Lowest since issue 1.4

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
168.6 USD
Average target price
183 USD
Spread / Average Target
+8.57%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW